115 related articles for article (PubMed ID: 19107967)
1. Amino acids of Coxsackie B5 virus are critical for infection of the murine insulinoma cell line, MIN-6.
Al-Hello H; Ylipaasto P; Smura T; Rieder E; Hovi T; Roivainen M
J Med Virol; 2009 Feb; 81(2):296-304. PubMed ID: 19107967
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo.
Al-Hello H; Davydova B; Smura T; Kaialainen S; Ylipaasto P; Saario E; Hovi T; Rieder E; Roivainen M
J Med Virol; 2005 Apr; 75(4):566-74. PubMed ID: 15714484
[TBL] [Abstract][Full Text] [Related]
3. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.
Yin H; Berg AK; Westman J; Hellerström C; Frisk G
J Med Virol; 2002 Dec; 68(4):544-57. PubMed ID: 12376963
[TBL] [Abstract][Full Text] [Related]
4. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
Zaini Z; Phuektes P; McMinn P
Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
[TBL] [Abstract][Full Text] [Related]
5. Complete nucleotide sequence of a coxsackievirus B4 strain that establishes infection in ICR mice pancreas and induces glucose intolerance.
Zhou M; Li F
Anat Rec (Hoboken); 2008 May; 291(5):601-9. PubMed ID: 18384052
[TBL] [Abstract][Full Text] [Related]
6. Evolution of coxsackie B virus during in vitro persistent infection: detection of protein mutations using two-dimensional polyacrylamide gel electrophoresis.
McLaren J; Argo E; Cash P
Electrophoresis; 1993; 14(1-2):137-47. PubMed ID: 8385003
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 replication and persistence in intestinal cells from mice infected orally and in the human CaCo-2 cell line.
Harrath R; Bourlet T; Delézay O; Douche-Aourik F; Omar S; Aouni M; Pozzetto B
J Med Virol; 2004 Oct; 74(2):283-90. PubMed ID: 15332278
[TBL] [Abstract][Full Text] [Related]
10. Effect of heat on the survival of infectious coxsackievirus B3 and its genome in water.
Gantzer C; Levi Y; Schwartzbrod L
Zentralbl Hyg Umweltmed; 1996 Nov; 199(1):76-83. PubMed ID: 9353546
[TBL] [Abstract][Full Text] [Related]
11. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
12. In vitro infection of mouse pancreatic islet cells with coxsackie viruses.
Bopegamage SA; Petrovicová A
Acta Virol; 1994 Oct; 38(5):251-5. PubMed ID: 7725998
[TBL] [Abstract][Full Text] [Related]
13. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK; Olsson A; Korsgren O; Frisk G
Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
[TBL] [Abstract][Full Text] [Related]
14. A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
Roivainen M; Alakulppi N; Ylipaasto P; Eskelinen M; Paananen A; Airaksinen A; Hovi T
J Virol Methods; 2005 Dec; 130(1-2):108-16. PubMed ID: 16055201
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus infection of mice. I. Viral kinetics and histopathological changes in mice experimentally infected with coxsackieviruses B3 and B4 by oral route.
Bopegamage S; Borsanyiová M; Vargová A; Petrovicová A; Benkovicová M; Gomolcák P
Acta Virol; 2003; 47(4):245-51. PubMed ID: 15068380
[TBL] [Abstract][Full Text] [Related]
16. Efficient infection of buffalo rat liver-resistant cells by encephalomyocarditis virus requires binding to cell surface sialic acids.
Guy M; Chilmonczyk S; Crucière C; Eloit M; Bakkali-Kassimi L
J Gen Virol; 2009 Jan; 90(Pt 1):187-96. PubMed ID: 19088288
[TBL] [Abstract][Full Text] [Related]
17. Increased gelatinase B/matrix metalloproteinase 9 (MMP-9) activity in a murine model of acute coxsackievirus B4-induced pancreatitis.
De Palma AM; Verbeken E; Van Aelst I; Van den Steen PE; Opdenakker G; Neyts J
Virology; 2008 Dec; 382(1):20-7. PubMed ID: 18929380
[TBL] [Abstract][Full Text] [Related]
18. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance.
Hindersson M; Orn A; Harris RA; Frisk G
Arch Virol; 2004 Oct; 149(10):1985-2000. PubMed ID: 15669109
[TBL] [Abstract][Full Text] [Related]
19. [Pancreatic lesion in newborn mice caused by Coxsackie B1 virus].
Fingerland A; Vonfracková A; Horacek J
Arkh Patol; 1978; 40(12):16-22. PubMed ID: 217317
[TBL] [Abstract][Full Text] [Related]
20. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.
Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D
Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
